Skip to main content

Table 3 Resistance status to rifampicin by GeneXpert MTB/RIF on paired spot specimens and morning specimens

From: Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin

Morning specimen Spot specimen
Resistant Susceptible Total
Resistant 2 2* 4
Susceptible 0 148 148
Total 2 150 152
  1. *Confirmed as RIF-susceptible by repeat GeneXpert MTB/RIF and phenotypic drug-susceptibility testing